Right now, technology is giving us a more refined, clear understanding of cancer at a genomic level. We’ve discovered that breast cancers can have great variability, even within a single patient, and this information is crucial to new therapies.
One area my colleagues and I have been focused on is patients who typically receive chemotherapy before surgery. By performing biopsies and...